Back

Pembrolizumab as a rare etiology of myocarditis

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Cardio-oncology 4 Clinical HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Mr Miguel De La Serna Real De Asua

University Hospital Getafe, Madrid (Spain)

4 More presentations in this session

Presentation thumbnail
Osimertinib-induced heart failure.
Doctor B. Andrade (Santarem, PT)
Slides Video
Presentation thumbnail
Complex cardiovascular manifestations after cancer treatment: a case of severe aortic and mitral stenosis with coronary artery disease
Doctor R. Fernandes (Coimbra, PT)
Slides Video
Presentation thumbnail
Primary cardiac diffuse large B-cell lymphoma: when the cause of heart failure is so massively unexpected
Doctor M. Martinho (Almada, PT)
Slides Video
Presentation thumbnail
A rare case of diffuse large B-cell lymphoma with cardiac involvement
Doctor I. Martins Moreira (Vila Real, PT)
Slides Video

Access the full session

Session thumbnail
Cardio-oncology 4

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Immune checkpoint inhibitor-associated myocarditis: a rare presentation with electrical storm in a young patient with Hodgkin lymphoma
thumbnail
Congress Presentation
When an anticancer drug silently attacks the heart - severe but due to diabetic neuropathy oligosymptomatic immune checkpoint inhibitor-associated perimyocarditis with LV outflow tract obstruction
thumbnail
Congress Presentation
Immune checkpoint inhibitor associated myocarditis - lessons from a case series

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources